Explore 3 Stock Ideas & Industry Insights Download Free Report

China Medical & HealthCare Group Limited

Healthcare US COLRF

0.08USD
0.00(0%)

Last update at 2026-06-18T13:30:00Z

Day Range

0.080.08
LowHigh

52 Week Range

0.060.09
LowHigh

Fundamentals

  • Previous Close 0.08
  • Market Cap86.42M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA153.22M
  • Revenue TTM1638.18M
  • Revenue Per Share TTM1.51
  • Gross Profit TTM 275.37M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -0.46900M 57.00M 35.40M -117.16900M -110.46800M
Minority interest -6.01000M -13.20300M -9.19700M -4.42900M -10.02600M
Net income -26.81600M 28.77M 11.29M -123.57400M -137.29600M
Selling general administrative 230.95M 223.68M 231.01M 255.21M 222.76M
Selling and marketing expenses - 6.87M 5.75M 4.04M 2.67M
Gross profit 309.55M 324.55M 286.22M 161.87M 175.97M
Reconciled depreciation 93.47M 97.31M 98.22M 104.69M 104.53M
Ebit - 86.12M 76.61M -58.15400M -52.22000M
Ebitda - 183.43M 174.83M 46.54M 52.31M
Depreciation and amortization - 97.31M 98.22M 104.69M 104.53M
Non operating income net other - - - - -
Operating income 52.98M 86.12M 83.21M -39.25900M -21.06100M
Other operating expenses - 1541.08M 1485.61M 1478.12M 1497.60M
Interest expense 22.37M 29.11M 47.81M 59.02M 58.25M
Tax provision 20.34M 15.03M 14.91M 1.98M 16.80M
Interest income 21.80M 32.50M 24.47M 3.96M 1.42M
Net interest income -0.57500M 3.38M -23.34100M -55.05700M -56.82500M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 15.03M 14.91M 1.98M 16.80M
Total revenue 1638.18M 1627.20M 1568.82M 1438.87M 1476.54M
Total operating expenses 1585.20M 238.44M 203.01M 201.12M 197.03M
Cost of revenue 1328.63M 1302.65M 1282.60M 1277.00M 1300.57M
Total other income expense net - -29.11400M -47.80700M -59.01500M -58.24800M
Discontinued operations - - - - -
Net income from continuing ops -20.80600M 41.98M 20.49M -119.14500M -127.27000M
Net income applicable to common shares - - - -123.57400M -137.29600M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 3548.53M 3538.88M 3617.39M 3232.53M 3489.54M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - 7.52M 79.57M 59.32M 104.73M
Total liab 1689.79M 1644.05M 1707.05M 1653.67M 1772.28M
Total stockholder equity 1773.36M 1818.97M 1872.49M 1554.94M 1700.60M
Deferred long term liab - - - - -
Other current liab 50.39M 476.56M 426.93M 226.91M 299.51M
Common stock - 10.86M 10.86M 7.24M 7.24M
Capital stock 10.81M 10.86M 10.86M 7.24M 7.24M
Retained earnings 1917.70M 1944.51M -429.96500M -441.26000M -317.68600M
Other liab - - - 94.73M 68.16M
Good will 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Other assets - - - 587.20M 812.53M
Cash 743.02M 885.43M 890.27M 614.08M 637.16M
Cash and equivalents - - - - -
Total current liabilities 1183.73M 1165.70M 1144.87M 1130.72M 1338.47M
Current deferred revenue - - 53.86M 40.74M 40.78M
Net debt 148.65M -49.22000M -91.63400M 364.94M 334.79M
Short term debt - 392.36M 315.95M 550.79M 606.31M
Short long term debt 457.50M 390.82M 312.56M 544.82M 603.53M
Short long term debt total - 836.21M 798.63M 979.02M 971.96M
Other stockholder equity - 2602.68M 2291.59M 2621.37M 2621.37M
Property plant equipment - - - 1611.10M 1694.11M
Total current assets 1297.91M 1359.21M 1360.77M 1033.43M 982.10M
Long term investments - - - - -
Net tangible assets - - - 1554.94M 1700.60M
Short term investments 34.73M 4.95M 0.26M 0.32M 4.68M
Net receivables 166.54M 173.02M 83.49M 94.65M 178.09M
Long term debt 434.17M 442.57M 447.49M 388.79M 316.41M
Inventory 241.51M 288.29M 307.19M 312.61M 147.37M
Accounts payable 139.34M 183.44M 227.52M 159.99M 230.49M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -794.56400M -635.45200M -632.41200M -610.33100M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 549.28M 546.18M -42.20300M -20.87800M
Deferred long term asset charges - - - - -
Non current assets total 2250.62M 2179.67M 2256.63M 1611.90M 1694.91M
Capital lease obligations 0.81M 2.83M 38.58M 45.42M 52.02M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -25.55000M -134.58900M -178.82600M -98.62400M -185.06500M
Change to liabilities - - - 0.00000M 139.84M
Total cashflows from investing activities - -134.58900M -178.82600M -134.33800M -160.17000M
Net borrowings 54.32M 78.18M -154.97700M 91.68M -79.14900M
Total cash from financing activities - 29.12M 100.57M 88.92M -79.14900M
Change to operating activities - - - - -18.70100M
Net income -26.81600M 57.00M 11.29M -123.57400M -137.29600M
Change in cash -148.18700M -4.83800M 301.22M -23.07900M -12.45100M
Begin period cash flow 885.43M 890.27M 589.05M 637.16M 649.61M
End period cash flow 743.02M 885.43M 890.27M 614.08M 637.16M
Total cash from operating activities 126.29M 105.97M 356.08M 15.38M 219.56M
Issuance of capital stock - 0.00000M 309.29M 0.00000M -
Depreciation 93.47M 97.31M 98.22M 104.69M 104.53M
Other cashflows from investing activities - 58.29M 15.74M 39.34M -30.59700M
Dividends paid -22.66100M 10.86M - - -
Change to inventory 0.64M 2.24M -12.70000M -8.11200M 17.93M
Change to account receivables - -71.60100M -34.33600M 43.12M -16.26900M
Sale purchase of stock -3.53900M -0.86900M 0.00000M - -
Other cashflows from financing activities - -37.33100M 261.49M -2.76500M -4.20100M
Change to netincome - - - - 128.10M
Capital expenditures 195.45M 192.88M 198.05M 137.97M 154.47M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -63.33500M -93.27700M 184.06M -52.32700M 122.80M
Stock based compensation - - - - -
Other non cash items 0.57M 48.97M 62.51M 86.59M 129.52M
Free cash flow -69.15900M -86.90700M 158.03M -122.58300M 65.09M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
COLRF
China Medical & HealthCare Group Limited
- -% 0.08 - - 0.05 0.49 0.09 -4.7193
HCA
HCA Healthcare, Inc.
1.82 0.49% 376.99 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR
0.03 0.27% 11.30 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
- -% 5.33 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc
- -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

Profile

Tian An Medicare Limited, an investment holding company, primarily operates hospitals in the People's Republic of China and Hong Kong. It operates through Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments segments. The company also involved in property development of independent living units and project management of health campus with a focus on eldercare and retirement community including elderly nursing home, service apartments, independent living units and commercial area comprising shopping mall, retail shops, and club hall facilities. In addition, it develops and sells properties and lands; leases residential and office properties; and provides loan financial and healthcare services, as well as trading of securities listed in overseas exchange. The company was formerly known as China Medical & HealthCare Group Limited and changed its name to Tian An Medicare Limited in April 2024. Tian An Medicare Limited was incorporated in 1989 and is based in Wan Chai, Hong Kong. The company operates as a subsidiary of Tian An China Investments Company Limited.

China Medical & HealthCare Group Limited

Rooms 1904B-5, 19/F, Wan Chai, Hong Kong

Key Executives

Name Title Year Born
Mr. Meibao Guo Executive Director 1974
Ms. Po Ling Sit Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions